Here we reported that the expression of miR-23a was higher in breast cancer cells with high metastasis ability and patients with lymph node metastasis and the treatment of TGF-β1 significantly upregulated the expression of miR-23a in breast cancer cells. The gene discussed is TGFB1; the disease is metastatic malignant neoplasm in the lymph nodes.